Effects of clopidogrel on the rebound hypercoagulable state after heparin discontinuation in patients with acute coronary syndromes

被引：17

作者：

Di Nisio, M ^{[1
]}

Bijsterveld, NR ^{[1
]}

Meijers, JCM ^{[1
]}

Levi, M ^{[1
]}

Büller, HR ^{[1
]}

Peters, RJG ^{[1
]}

机构：

[1] Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2005年 / 46卷 / 08期

关键词：

D O I：

10.1016/j.jacc.2005.07.028

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1582 / 1583

页数：2

共 9 条

[1] Thrombin generation after the abrupt cessation of intravenous unfractionated heparin among patients with acute coronary syndromes - Potential mechanisms for heightened prothrombotic potential [J].

Becker, RC ;

Spencer, FA ;

Li, YF ;

Ball, SP ;

Ma, YS ;

Hurley, T ;

Hebert, J .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (04) :1020-1027

[2] Rebound thrombin generation after heparin therapy in unstable angina -: A Randomized comparison between unfractionated and low-molecular-weight heparin [J].

Bijsterveld, NR ;

Moons, AH ;

Meijers, JCM ;

Tijssen, JGP ;

Büller, HR ;

Levi, M ;

Peters, RJG .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (05) :811-817

[3] Effect of high- and low-molecular-weight heparins on thrombin-thrombomodulin interaction and protein C activation [J].

De Cristofaro, R ;

De Candia, E ;

Landolfi, R .

CIRCULATION, 1998, 98 (13) :1297-1301

[4] Clopidogrel does not suppress blood markers of coagulation activation in aspirin-treated patients with non-ST-elevation acute coronary syndromes [J].

Eikelboom, JW ;

Weitz, JI ;

Budaj, A ;

Zhao, F ;

Copland, I ;

Maciejewski, P ;

Johnston, M ;

Yusuf, S .

EUROPEAN HEART JOURNAL, 2002, 23 (22) :1771-1779

[5] REBOUND INCREASE IN THROMBIN GENERATION AND ACTIVITY AFTER CESSATION OF INTRAVENOUS HEPARIN IN PATIENTS WITH ACUTE CORONARY SYNDROMES [J].

GRANGER, CB ;

MILLER, JM ;

BOVILL, EG ;

GRUBER, A ;

TRACY, RP ;

KRUCOFF, MW ;

GREEN, C ;

BERRIOS, E ;

HARRINGTON, RA ;

OHMAN, EM ;

CALIFF, RM .

CIRCULATION, 1995, 91 (07) :1929-1935

[6] Antithrombotic therapy for coronary artery disease [J].

Harrington, RA ;

Becker, RC ;

Ezekowitz, A ;

Meade, TW ;

O'Connor, CM ;

Vorchheimer, DA ;

Guyatt, GH .

CHEST, 2004, 126 (03) :513S-548S

[7] Attenuation of rebound ischemia after discontinuation of heparin therapy by glycoprotein IIb/IIIa inhibition with eptifibatide in patients with acute coronary syndromes - Observations from the platelet IIb/IIIa in unstable angina: Receptor suppression using integrilin therapy (PURSUIT) trial [J].

Lauer, MA ;

Houghtaling, PL ;

Peterson, JG ;

Granger, CB ;

Bhatt, DL ;

Sapp, SK ;

Simoons, ML ;

Harrington, RA ;

Topol, EJ ;

Lincoff, AM .

CIRCULATION, 2001, 104 (23) :2772-2777

[8] Thrombin inhibitors suppress the thrombin-thrombomodulin-mediated generation of activated protein C [J].

Linder, R ;

Blombäck, M ;

Egberg, N ;

Grip, L .

THROMBOSIS RESEARCH, 1999, 95 (02) :117-125

[9] REACTIVATION OF UNSTABLE ANGINA AFTER THE DISCONTINUATION OF HEPARIN [J].

THEROUX, P ;

WATERS, D ;

LAM, J ;

JUNEAU, M ;

MCCANS, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (03) :141-145

← 1 →